Bruce Luxon, MD, PhD is the former chairman and chief of service for the Department of Medicine at Georgetown University Hospital, Washington. He remains a vice president for clinical research at Georgetown University Medical Center. His clinical focus is in hepatology, with expertise in autoimmune hepatitis, cholestatic liver diseases and viral hepatitis, including hepatitis B and C.

Chris Burns is an Emmy Award-winning cinematographer, filmmaker, and founder of Ayumi Creative, where he has spent more than two decades creating cinematic stories for Netflix, HBO Max, A&E, Discovery, national brands, and nonprofit organizations. His work is rooted in authentic human storytelling and the power of visual media to inspire action.

Andrea Wilson Woods is a writer, speaker, and patient advocate dedicated to improving liver cancer outcomes. She is the founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, named after her sister, who died from the disease at age 15. With a background in teaching, storytelling, and nonprofit leadership, she blends compassion with strategic insight to drive change in healthcare. Andrea's mission is to ensure no one faces liver cancer alone, turning personal loss into a powerful force for awareness and action.

Dr. Speliotes is the Keith Henley Endowed Professor of Gastroenterology and Computational Medicine and Bioinformatics at the University of Michigan. She is an internationally leader in the genetics of human obesity, MASLD, and cardiometabolic disease having identified thousands of genetic variants that cause these diseases. She developed bioinformatic methods to identify causal tissues, genes and pathways highlighted by genomic analyses.

Dr. Adnan Said is a Professor in the Division of Gastroenterology and Hepatology within the Department of Medicine at the University of Wisconsin (UW) School of Medicine and Public Health in Madison, WI. He also serves as program director of the UW Health Transplant hepatology Fellowship, Director of the UW Health Metabolic Liver Clinic and as Medical Director of the VA Liver Transplant Program.Dr.

Professor of Medicine, University of Washington, Director of Hepatology, Veterans Affairs Puget Sound Health Care System.
My areas of interest include liver cancer screening and risk stratification, clinical epidemiology of chronic liver disease, cirrhosis, and HCC, prediction modeling, target trial emulation and the role of cholesterol in MASLD.

Sharon H. Jaycox, PhD, is a strategic healthcare and patient advocacy executive with more than 12 years of experience advancing patient-centered research, clinical development integration, health equity, and community engagement across public health, liver disease, metabolic health, and clinical research. Most recently, Dr. Jaycox served as Liver Disease Program Director at the Global Liver Institute, where she led enterprise-level patient-strategy initiatives to raise awareness of liver and cardiometabolic diseases, advance research engagement, and influence policy.

Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has established a national and international presence in hepatology patient advocacy, with a focus on multidisciplinary collaboration, health equity, and incorporating the lived experience of people affected by liver disease into clinical care, research, and education.

I am a gastroenterologist and hepatologist at Yale School of Medicine with a research focus on decision science in liver cancer screening and gene-environment interactions that influence liver cancer risk.

Dr. Mamatha Bhat is a Hepatologist and leads the Transplant AI initiative at the University Health Network's Ajmera Transplant Centre, and Associate Professor of Medicine at the University of Toronto. Dr. Bhat completed her medical school and residency training at McGill University. She then completed a Transplant Hepatology fellowship at the Mayo Clinic in Rochester, Minnesota, followed by a Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals, through which she completed a PhD.